41
Growth Score in past quarter
pts
Heat Score 41 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4066540
Alfama is a pharmaceutical company that develops Carbon Monoxide-Releasing Molecules (CORMs) for therapy.
About the Company
Alfama is a pharmaceutical company that develops Carbon Monoxide-Releasing Molecules (CORMs) for therapy. The company has produced hundreds of CORMs and obtained exceptional results in various animal models of chronic and acute human diseases. CORMs have the potential to expand CO-based therapy to a wide range of high-value indications, can be
administered orally or intravenously, and offer a very attractive therapeutic window and safety profile.
It is based in Boston, Massachusetts.
